ZNF467
gene geneOn this page
Also known as EZIZfp467
Summary
ZNF467 (zinc finger protein 467, HGNC:23154) is a protein-coding gene on chromosome 7q36.1, encoding Zinc finger protein 467 (Q7Z7K2). Transcription factor that promotes adipocyte differentiation and suppresses osteoblast differentiation in the bone marrow.
The protein encoded by this gene is a zinc finger protein whose function has not yet been elucidated in humans. However, the mouse ortholog of this protein enhances adipocyte differentiation and suppresses osteoblast differentiation in bone marrow. The mouse protein also is a transcription factor for several genes and can help recruit histone deacetylase complexes.
Source: NCBI Gene 168544 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 140 total
- MANE Select transcript:
NM_207336
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23154 |
| Approved symbol | ZNF467 |
| Name | zinc finger protein 467 |
| Location | 7q36.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | EZI, Zfp467 |
| Ensembl gene | ENSG00000181444 |
| Ensembl biotype | protein_coding |
| OMIM | 614040 |
| Entrez | 168544 |
Gene structure
Transcript identifiers
Ensembl transcripts: 34 — 34 protein_coding
ENST00000302017, ENST00000484747, ENST00000882861, ENST00000882862, ENST00000882863, ENST00000882864, ENST00000882865, ENST00000882866, ENST00000882867, ENST00000882868, ENST00000882869, ENST00000882870, ENST00000882871, ENST00000882872, ENST00000882873, ENST00000882874, ENST00000882875, ENST00000882876, ENST00000882877, ENST00000882878, ENST00000882879, ENST00000882880, ENST00000882881, ENST00000882882, ENST00000882883, ENST00000882884, ENST00000882885, ENST00000882886, ENST00000882887, ENST00000882888, ENST00000882889, ENST00000951627, ENST00000951628, ENST00000951629
RefSeq mRNA: 2 — MANE Select: NM_207336
NM_001329856, NM_207336
CCDS: CCDS5899, CCDS87563
Canonical transcript exons
ENST00000302017 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001142582 | 149764182 | 149766239 |
| ENSE00001339175 | 149769090 | 149769200 |
| ENSE00001339178 | 149770440 | 149770556 |
| ENSE00001339180 | 149770999 | 149771074 |
| ENSE00001882896 | 149773108 | 149773588 |
Expression profiles
Bgee: expression breadth ubiquitous, 195 present calls, max score 92.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.8099 / max 506.9993, expressed in 1224 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 86744 | 9.3380 | 1205 |
| 86742 | 0.4719 | 250 |
Top tissues by expression
278 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 92.46 | gold quality |
| granulocyte | CL:0000094 | 92.44 | gold quality |
| leukocyte | CL:0000738 | 92.43 | gold quality |
| mononuclear cell | CL:0000842 | 92.40 | gold quality |
| blood | UBERON:0000178 | 91.84 | gold quality |
| endometrium epithelium | UBERON:0004811 | 89.25 | gold quality |
| metanephros cortex | UBERON:0010533 | 82.90 | gold quality |
| spleen | UBERON:0002106 | 82.62 | gold quality |
| apex of heart | UBERON:0002098 | 82.38 | gold quality |
| left uterine tube | UBERON:0001303 | 81.33 | gold quality |
| putamen | UBERON:0001874 | 80.63 | gold quality |
| body of stomach | UBERON:0001161 | 80.43 | gold quality |
| bone marrow cell | CL:0002092 | 79.62 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 79.49 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 79.43 | gold quality |
| right lung | UBERON:0002167 | 79.35 | gold quality |
| caudate nucleus | UBERON:0001873 | 79.27 | gold quality |
| adenohypophysis | UBERON:0002196 | 79.19 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 78.93 | gold quality |
| right lobe of liver | UBERON:0001114 | 78.77 | gold quality |
| upper lobe of lung | UBERON:0008948 | 78.73 | gold quality |
| omental fat pad | UBERON:0010414 | 78.40 | gold quality |
| peritoneum | UBERON:0002358 | 78.33 | gold quality |
| bone marrow | UBERON:0002371 | 78.32 | gold quality |
| thyroid gland | UBERON:0002046 | 78.05 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 77.98 | gold quality |
| pancreatic ductal cell | CL:0002079 | 77.96 | silver quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 77.95 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.90 | gold quality |
| stomach | UBERON:0000945 | 77.79 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting ZNF467, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4738-3P | 98.98 | 67.98 | 1846 |
| HSA-MIR-3074-5P | 98.82 | 66.56 | 1414 |
| HSA-MIR-4686 | 98.77 | 66.87 | 964 |
| HSA-MIR-4297 | 98.77 | 66.95 | 2013 |
| HSA-MIR-7977 | 98.65 | 66.18 | 2590 |
| HSA-MIR-6827-5P | 98.46 | 64.88 | 1256 |
| HSA-MIR-5589-5P | 98.34 | 64.82 | 1148 |
| HSA-MIR-134-3P | 96.83 | 66.22 | 1001 |
| HSA-MIR-4296 | 96.35 | 63.55 | 1233 |
| HSA-MIR-4734 | 88.28 | 63.44 | 87 |
Literature-anchored findings (GeneRIF, showing 3)
- These results identify EZI as a novel cargo protein for importin-7 and demonstrate a nucleocytoplasmic shuttling mechanism that is mediated by importin-7-dependent nuclear localization and CRM1-independent nuclear export. (PMID:17848547)
- ZNF467 gene DNA methylation is importants in the pathogenesis of idiopathic pulmonary fibrosis. (PMID:22700861)
- demonstrate that PCBP2 and ZNF467 impact adipogenic but not osteogenic differentiation, further supporting evidence that AMSCs and BMSCs appear to be adapted to their microenvironment (PMID:32032745)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp467 | ENSMUSG00000068551 |
| rattus_norvegicus | Zfp467 | ENSRNOG00000007707 |
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391), ZNF777 (ENSG00000196453)
Protein
Protein identifiers
Zinc finger protein 467 — Q7Z7K2 (reviewed: Q7Z7K2)
All UniProt accessions (2): C9JAX3, Q7Z7K2
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor that promotes adipocyte differentiation and suppresses osteoblast differentiation in the bone marrow. Enhances the osteoclast-supporting ability of stromal cells. Binds with STAT3 the consensus sequence 5’-CTTCTGGGAAGA-3’ of the acute phase response element (APRE). Transactivates several promoters including FOS, OSM and PPARG. Recruits a histone deacetylase complex.
Subunit / interactions. Interacts with STAT3. Enhances STAT3 activity by keeping it in the nucleus.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (2): NP_001316785, NP_997219* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050717 | C2H2-ZF_Transcription_Reg | Family |
Pfam: PF00096
UniProt features (19 total): zinc finger region 12, region of interest 2, cross-link 2, chain 1, compositionally biased region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z7K2-F1 | 65.99 | 0.02 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 97, 368
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation |
MSigDB gene sets: 142 (showing top):
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP, SANSOM_APC_TARGETS_DN, GNF2_HCK, MULLIGHAN_NPM1_SIGNATURE_3_DN, WALLACE_PROSTATE_CANCER_RACE_DN, ACEVEDO_LIVER_CANCER_UP, IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM, CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP, WGGAATGY_TEF1_Q6, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, CHENG_IMPRINTED_BY_ESTRADIOL, MARTENS_TRETINOIN_RESPONSE_UP, DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Adipogenesis | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
664 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF467 | TTYH3 | Q9C0H2 | 412 |
| ZNF467 | ZNF395 | Q9H8N7 | 365 |
| ZNF467 | C7orf33 | Q8WU49 | 348 |
| ZNF467 | PWWP3B | Q5H9M0 | 324 |
| ZNF467 | DRC11L | A6NCM1 | 323 |
| ZNF467 | ZNF638 | Q14966 | 321 |
| ZNF467 | WDR86 | Q86TI4 | 316 |
| ZNF467 | A0A087WTJ2 | A0A087WTJ2 | 301 |
| ZNF467 | ZNF862 | O60290 | 294 |
| ZNF467 | ZBED10P | Q96FA7 | 290 |
| ZNF467 | ATP6V0E2 | Q8NHE4 | 289 |
| ZNF467 | KRABD3 | A5PL33 | 285 |
| ZNF467 | SLC37A1 | P57057 | 272 |
| ZNF467 | PGBD4 | Q96DM1 | 270 |
| ZNF467 | LRRC61 | Q9BV99 | 267 |
IntAct
19 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP12-3 | ZNF467 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF467 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| LMO4 | ZNF467 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLE5 | ZNF467 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF467 | L3MBTL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF467 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| ZNF467 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF467 | TARBP2 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF467 | KRTAP12-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF467 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| LMO4 | ZNF467 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF467 | TLE5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| L3MBTL2 | ZNF467 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (175): ZNF467 (Affinity Capture-MS), ZNF467 (Affinity Capture-MS), ZNF467 (Affinity Capture-MS), ZNF467 (Affinity Capture-RNA), ZNF467 (Affinity Capture-MS), ZNF467 (Two-hybrid), ZNF467 (Two-hybrid), ZNF467 (Two-hybrid), ZNF467 (Two-hybrid), KRTAP12-3 (Two-hybrid), STRBP (Affinity Capture-MS), GTPBP4 (Affinity Capture-MS), DDX55 (Affinity Capture-MS), ZNF317 (Affinity Capture-MS), YTHDC2 (Affinity Capture-MS)
ESM2 similar proteins: A2CE44, A6NFI3, A6NM28, A8K8V0, O15370, O70218, O95201, P0CJ78, P10075, P10754, P28698, P70338, Q04890, Q07120, Q14V87, Q19A40, Q569E7, Q58DK7, Q5DWN0, Q5FWU5, Q5RJR4, Q5T619, Q5TEC3, Q6DD87, Q6IQX8, Q6PD29, Q6PGE4, Q6ZMY9, Q7Z7K2, Q80VM4, Q8BIF9, Q8JZL0, Q8N8E2, Q8NAF0, Q8NCA9, Q8TD94, Q8WUU4, Q96C55, Q96H86, Q96MX3
Diamond homologs: Q5RJR4, Q6A085, Q7Z7K2, Q8BI67, Q8JZL0, Q9UDV6, A6QR00, P0CG23, P18735, Q569E7, Q5TEC3, Q6H236, Q6ZNH5, Q8BI66, Q8BI73, Q8NF99, Q8TF50, Q9H7R5, Q9NSD4, Q8NAF0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
140 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 127 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1041 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:149766240:C:CC | acceptor_gain | 1.0000 |
| 7:149766235:CTCTC:C | acceptor_gain | 0.9900 |
| 7:149766237:CTC:C | acceptor_gain | 0.9900 |
| 7:149766237:CTCCT:C | acceptor_loss | 0.9900 |
| 7:149766238:TC:T | acceptor_gain | 0.9900 |
| 7:149766239:CC:C | acceptor_gain | 0.9900 |
| 7:149766240:C:CG | acceptor_loss | 0.9900 |
| 7:149766241:T:A | acceptor_loss | 0.9900 |
| 7:149766236:TCTC:T | acceptor_gain | 0.9800 |
| 7:149766237:CTCC:C | acceptor_gain | 0.9800 |
| 7:149766238:TCCT:T | acceptor_gain | 0.9800 |
| 7:149766249:C:CT | acceptor_gain | 0.9800 |
| 7:149773102:CCTTA:C | donor_loss | 0.9800 |
| 7:149773103:CTTA:C | donor_loss | 0.9800 |
| 7:149773104:TTAC:T | donor_loss | 0.9800 |
| 7:149773105:TACCT:T | donor_loss | 0.9800 |
| 7:149773106:ACCTG:A | donor_loss | 0.9800 |
| 7:149773107:CCTGG:C | donor_gain | 0.9800 |
| 7:149770997:AC:A | donor_gain | 0.9600 |
| 7:149770998:CC:C | donor_gain | 0.9600 |
| 7:149776090:GG:G | donor_gain | 0.9600 |
| 7:149776091:GG:G | donor_gain | 0.9600 |
| 7:149773101:CCCTT:C | donor_loss | 0.9500 |
| 7:149776344:AGGC:A | acceptor_gain | 0.9500 |
| 7:149776345:GGCG:G | acceptor_gain | 0.9500 |
| 7:149770993:GCTCA:G | donor_loss | 0.9400 |
| 7:149770994:CTCA:C | donor_loss | 0.9400 |
| 7:149770995:T:TA | donor_loss | 0.9400 |
| 7:149770996:C:CA | donor_loss | 0.9400 |
| 7:149770997:A:AC | donor_gain | 0.9400 |
AlphaMissense
3876 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:149765575:G:C | F309L | 1.000 |
| 7:149765575:G:T | F309L | 1.000 |
| 7:149765576:A:G | F309S | 1.000 |
| 7:149765577:A:G | F309L | 1.000 |
| 7:149765659:A:C | F281L | 1.000 |
| 7:149765659:A:T | F281L | 1.000 |
| 7:149765660:A:G | F281S | 1.000 |
| 7:149765661:A:G | F281L | 1.000 |
| 7:149765716:G:C | H262Q | 1.000 |
| 7:149765716:G:T | H262Q | 1.000 |
| 7:149765718:G:C | H262D | 1.000 |
| 7:149765743:G:C | F253L | 1.000 |
| 7:149765743:G:T | F253L | 1.000 |
| 7:149765744:A:G | F253S | 1.000 |
| 7:149765745:A:G | F253L | 1.000 |
| 7:149765827:G:C | F225L | 1.000 |
| 7:149765827:G:T | F225L | 1.000 |
| 7:149765829:A:G | F225L | 1.000 |
| 7:149764846:G:C | F552L | 0.999 |
| 7:149764846:G:T | F552L | 0.999 |
| 7:149764848:A:G | F552L | 0.999 |
| 7:149764930:G:C | F524L | 0.999 |
| 7:149764930:G:T | F524L | 0.999 |
| 7:149764932:A:G | F524L | 0.999 |
| 7:149765014:G:C | F496L | 0.999 |
| 7:149765014:G:T | F496L | 0.999 |
| 7:149765016:A:G | F496L | 0.999 |
| 7:149765548:G:C | H318Q | 0.999 |
| 7:149765548:G:T | H318Q | 0.999 |
| 7:149765577:A:T | F309I | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000114805 (7:149778201 C>G,T), RS1000397745 (7:149778514 G>A), RS1000880283 (7:149771777 C>T), RS1000934386 (7:149776173 G>A), RS1001655446 (7:149773984 G>A), RS1001748341 (7:149767237 G>A), RS1002125428 (7:149775898 A>G), RS1002460619 (7:149774768 C>T), RS1002471966 (7:149777557 C>A,G,T), RS1002625543 (7:149772083 C>T), RS1002700966 (7:149767997 G>C,T), RS1002743566 (7:149774965 G>A,T), RS1002777916 (7:149769547 C>A,G,T), RS1003141688 (7:149767627 T>C), RS1004138378 (7:149773417 C>A)
Disease associations
OMIM: gene MIM:614040 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006626_28 | Pulse pressure | 2.000000e-11 |
| GCST009698_126 | Metabolite levels | 2.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005763 | pulse pressure measurement |
| EFO:0005059 | acylcarnitine measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
45 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression, increases methylation, affects cotreatment, decreases expression | 7 |
| entinostat | decreases expression, affects cotreatment | 2 |
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Cisplatin | affects expression, decreases expression | 2 |
| Estradiol | decreases expression, affects cotreatment | 2 |
| Particulate Matter | increases abundance, increases expression, decreases expression | 2 |
| TAK-243 | affects sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| geraniol | increases expression | 1 |
| lead acetate | decreases expression | 1 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| afimoxifene | decreases expression, decreases reaction | 1 |
| 2,3-bis(3’-hydroxybenzyl)butyrolactone | affects cotreatment, decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| clothianidin | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| gardiquimod | decreases expression, decreases reaction | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Decitabine | affects expression | 1 |
| Zoledronic Acid | increases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation, affects methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.